Hyun D. Kim
Corporate Officer/Principal presso EMBER THERAPEUTICS, INC.
Profilo
Hyun D.
Kim is currently working as Vice President-Clinical Development at Ember Therapeutics, Inc. He previously worked as Director-Product Development at Anika Therapeutics, Inc., Director-Research & Development at Transport Pharmaceuticals, Inc., Director-Research & Development at Olympus Biotech Corp.
(United States), and Vice President-Clinical Development at Ember Therapeutics, Inc. Dr. Kim completed his undergraduate, graduate, and doctorate degrees from Brown University.
Posizioni attive di Hyun D. Kim
| Società | Posizione | Inizio |
|---|---|---|
| EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Hyun D. Kim
| Società | Posizione | Fine |
|---|---|---|
| Olympus Biotech Corp. (United States) | Direttore Tecnico/Scientifico/R&S | - |
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Direttore Tecnico/Scientifico/R&S | - |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di Hyun D. Kim
| Brown University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| EMBER THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Transport Pharmaceuticals, Inc.
Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
| Olympus Biotech Corp. (United States) |
- Borsa valori
- Insiders
- Hyun D. Kim
